Varian is a US-based manufacturer of cancer-treating medical devices and software, while Sirtex is an Australian life sciences company that develops interventional oncology therapies.
The acquisition will strengthen Varian Medical’s cancer care portfolio.
Chinese in-vitro diagnostic products manufacturer Guangdong Hybribio Biotech Co Ltd plans to acquire 21.87% stake in a life technology company located in Wuhan for CNY14m ($2.21m).
Paragon Care Ltd plans to acquire Anaequip Medical Pty Ltd for A$2.3m ($1.8m).
Paragon Care will pay A$1.84m ($1.48m) in cash and the remaining A$0.46m ($0.37m) through shares.
Based in Australia, Paragon is a medical equipment sourcing company, while Anaequip Medical, also based in Australia, is a medical equipment distributor.